Oncology Research Vol 25 pp 975988 Printed USA All rights reserved Copyright Ó 2017 Cognizant LLC 0965040717 9000 00 DOI httpsdoiorg103727096504016X14791726591124 EISSN 15553906 wwwcognizantcommunicationcom MicroRNA98 Plays Suppressive Role NonSmall Cell Lung Cancer Through Inhibition SALL4 Protein Expression Wenliang Liu Peng Xiao Han Wu Li Wang Demiao Kong Fenglei Yu Department Thoracic Surgery Second Xiangya Hospital Central South University Changsha Hunan PR China Department Thoracic Surgery Third Xiangya Hospital Central South University Changsha Hunan PR China MicroRNAs miRs demonstrated significantly associated development progres sion nonsmall cell lung cancer NSCLC However underlying mechanism miR98 mediating malignant phenotypes NSCLC cells remains obscure In study miR98 significantly downregulated NSCLC tissues compared nontumor lung tissues Downregulation miR98 signifi cantly associated poor differentiation advanced clinical stage Restoration miR98 expression sig nificantly decreased proliferation migration invasion NSCLC A549 H1229 cells SALL4 identified target gene miR98 protein expression SALL4 negatively regulated miR98 NSCLC A549 H1229 cells Overexpression SALL4 promoted A549 H1229 cell proliferation migration invasion reversed suppressive effects miR98 malignant phenotypes A549 H1229 cells Moreover SALL4 significantly upregulated NSCLC tissues compared nontumor lung tissues We observed inverse correlation miR98 SALL4 levels NSCLC tissues In vivo study revealed miR98 overexpression suppressed NSCLC growth In summary demonstrate miR98 acts tumor suppressor NSCLC cells inhibiting protein expression target gene SALL4 Therefore study highlights importance miR98SALL4 axis NSCLC Key words MicroRNAs miRs Nonsmall cell lung cancer NSCLC Tumor suppressor SALL4 INTRODUCTION Nonsmall cell lung cancer NSCLC accounts 85 lung cancers common NSCLCs adenocarcinoma squamous cell carcinoma largecell carcinoma nonsquamous cell carcinoma12 Although great improvements surgi cal resection radiotherapy chemotherapy survival patients latestage NSCLC remains unsatisfactory34 Studies recent years identi fied important oncogenes tumor suppressors involved NSCLC growth metastasis suggesting promising therapeutic targets56 Understanding molecular mechanisms underlying development progression NSCLC ben eficial development effective therapeutic strate gies disease MicroRNAs miRs kind small noncoding RNA molecules 2025 nucleotides length inhibit gene expression posttranscriptional level binding 3untranslated region UTR tar genes resulting mRNA degradation translation inhibition7 miRs participate biological processes cell proliferation differen tiation survival apoptosis motility89 Moreover deregulation miRs observed NSCLC function oncogenes tumor suppres sors miR9 miR21 miR145 miR367 forth1014 These miRs promising therapeutic targets candidates treatment NSCLC miR98 important member let7miR98 fam ily reported involved pathologi cal processes Alzheimers disease schizophrenia tumorigenesis1517 Wang et al miR98 suppressed cell proliferation migration invasion hepatocellular carcinoma targeting CTHRC118 Du et al miR98 inhibit growth metas tasis oral squamous cell carcinoma suppressing protein expression IGF1R19 In addition miR98 inhibit metastasis melanoma nega tive feedback loop target gene IL620 Recently miR98 inhibit malignant phenotypes NSCLC cells directly targeting ITGB3 Address correspondence Wenliang Liu MD Associate Professor Department Thoracic Surgery Second Xiangya Hospital Central South University 139 Renmin Middle Road Changsha 410011 Hunan PR China Tel 8673185295104 Fax 8673185295104 Email xiangyaliuwenliang163com 975 This article licensed Creative Commons AttributionNonCommercial NoDerivatives 40 International License 976 LIU ET AL PAK12122 As miR target genes7 targets miR98 exist NSCLC needs fully investigated Our study aimed investigate clinical significance miR98 expression NSCLC underly ing mechanism miR98 mediating proliferation migration invasion NSCLC cells MATERIALS AND METHODS Tissue Sample Collection The study approved ethics committee Second Xiangya Hospital Central South University Changsha PR China NSCLC tissues n 88 non tumor lung tissues n 15 collected hospital January 2010 March 2011 All written informed consents obtained The tissues confirmed pathologists hospital NSCLC patients receive preoperative radiotherapy chemotherapy After surgical resection tissues immediately snap fro zen liquid nitrogen stored 80C The clinico pathological information summarized Table 1 RealTime qPCR Assay Total RNA extracted TRIzol reagent Thermo Fisher Scientific Waltham MA USA according manufacturers instructions Reverse Transcription Kit Thermo Fisher convert RNA cDNA according manufacturers instructions For miR98 expression detection MiRNA QPCR Detection Kit GeneCopoeia Rockville MD USA duct realtime PCR ABI 7300 plus thermocycler U6 gene internal reference For mRNA detection QPCR Detection Kit Thermo Fisher conduct realtime PCR according manu facturers instructions GAPDH internal reference The PCR conditions 95C 5 min 40 cycles 95C 15 s 60C 30 s The relative expression miR mRNA analyzed 2DDCt method Cell Culture Transfection Normal lung epithelial cell line BEAS2B human NSCLC cell lines A549 HCC827 H1229 SKMES1 purchased Cell Bank Central South University Hunan Sheng PR China Cells cul tured Dulbeccos modified Eagles medium DMEM Thermo Fisher Scientific supplemented 10 fetal bovine serum FBS Thermo Fisher Scientific Cells cultured 37C humidified atmosphere 5 CO2 Cells passaged 3 days main tain exponential growth A549 H1229 cells transfected miR98 mimic scramble miR mimic miRNC miR98 inhibitor negative control NC inhibitor pcDNA31SALL4 expression plasmid blank Table 1 Association Between miR98 Expression Clinicopathologic Features Patients With NonSmall Cell Lung Cancer Variables Age years 60 ³60 Sex Male Female Hypotype Adenocarcinoma Squamous Differentiation Well moderated Poor Tumor size cm 3 ³3 TNM stage III IIIIV Smoking status Never Ever Low miR98 n 45 High miR98 n 43 No 25 63 67 21 49 39 37 51 40 48 25 63 16 72 14 31 35 10 24 21 13 32 18 27 8 37 6 39 11 32 32 11 25 18 24 19 22 21 17 26 10 33 The difference statistical significance p Value 064 0805 0674 0017 0392 0033 0276 miR98 INHIBITS NSCLC VIA TARGETING SALL4 977 pcDNA31 vector Lipofectime 2000 Thermo Fisher Scientific according manufacturers instructions Western Blot Cells lysed RIPA buffer extract proteins separated 12 SDSPAGE transferred polyvinylidene difluoride PVDF membrane Thermo Fisher Scientific The membrane incubated PBS containing 5 milk room temperature 3 h The PVDF membrane incubated primary antibodies including SALL4 Ecadherin Ncadherin fibronectin vimentin MMP2 MMP9 GAPDH Abcam Cambridge MA USA room temperature 3 h secondary antibody Abcam room temperature 1 h SuperSignal West Pico Chemiluminescent Substrate Kit Pierce Rockford IL USA detect signals according manufacturers instructions The relative protein expression analyzed ImagePro Plus 60 software Media Cybernetics Rockville MD USA represented density ratio versus GAPDH MTT Assay Cells plated density 10000 cells 96well plates After cultured 0 24 48 72 h cells incubated MTT 05 mgml 4 h 37C Then 150 mM DMSO solution added dis solve formazan crystals The absorbance read 570 nm microplate reader Wound Healing Assay Cells cultured confluence wounds approximately 1mm width created plastic scriber Cells washed PBS incubated DMEM FBS After wounding 24 h cells incubated DMEM 10 FBS After cultured 48 h cells observed microscope Transwell Assay Transwell chambers precoated Matrigel BD Bio sciences San Jose CA USA perform Transwell assay Cell suspension containing 5 105 cells ml prepared DMEM 300 μl added upper chamber Then 500 μl DMEM 10 FBS added lower chamber After cells incubated 37C 24 h cottontipped swab wipe cells pass pores Cells fixed 90 alcohol stained crystal violet observed microscope Bioinformatics Analysis Luciferase Reporter Assay TargetScan miRanda PicTar bioinformatics soft ware predict putative target genes miR98 according manufacturers instructions The wild type WT mutant type MT SALL4 3UTR cloned downstream firefly luciferase coding region pMIRGLOTM luciferase vector Promega Madison WI USA A549 H1229 cells cotransfected 200 ng WT MT SALL43UTR plasmid 100 ng miR98 mimic miRNC pRLTK plasmid Promega internal normalization After transfection 36 h luciferase activity examined Dual Luciferase Reporter Assay System Promega according manufac turers instructions Stable Transfection Tumor Growth Analysis Male BALBCnunu nude mice 8 weeks pur chased maintained specific pathogenfree ditions Animal Center Central South University Hunan Sheng PR China The mature miR98 SALL4 cloned pLPVSVG lentiviral vector A549 cells stably transfected pLPVSVGmiR98 plasmid pLPVSVGSALL4 plasmid blank vector Nude mice injected subcutaneously dorsal flank 1 107 A549 cells group Nude mice sacrificed 90 days tumor implantation Tumor weight determined Tumor volume calculated formula V mm3 05 b2 maxi mum length diameter b maximum trans verse diameter Statistical Analysis Data expressed mean SD separate experiments Independent ttests compare differences groups Qualitative data analyzed chisquare test Correlation determined Pearson correlation analysis SPSS 200 perform statistical analysis A value p 005 considered statistically significant RESULTS Downregulation miR98 Is Associated With Malignant Progression NSCLC In study realtime RTPCR deter miR98 expression level NSCLC tissues n 88 Nontumor lung tissues n 15 controls We miR98 significantly regulated NSCLC tissues compared nontumor lung tissues Fig 1A To confirm findings examined miR98 expression normal lung epithelial cell line BEAS2B human NSCLC cell lines includ ing A549 HCC827 H1229 SKMES1 Expression levels miR98 reduced NSCLC cell lines compared BEAS2B cells Fig 1B Therefore miR98 downregulated NSCLC We studied clinical significance miR98 expression NSCLC Based mean value miR98 expression 978 LIU ET AL Figure 1 miR98 downregulated NSCLC A Realtime qPCR conducted determine miR98 levels NSCLC tissues n 88 nontumor lung tissues n 15 p 001 versus Normal B Realtime qPCR conducted determine miR98 levels normal lung epithelial BEAS2B cells human NSCLC cell lines A549 HCC827 H1229 SKMES1 p 001 versus BEAS2B cutoff point NSCLC patients divided groups low miR98 expression group high miR98 expression group We low miR98 expression significantly associated poor differentiation advanced clinical stage age sex hypotype tumor size smoking status Table 1 Therefore suggest decreased expression miR98 associated malignant progression NSCLC miR98 Has Suppressive Effects NSCLC Cell Growth Metastasis In Vitro A549 H1229 study reg ulatory role miR98 NSCLC vitro As miR98 downregulated NSCLC tis sues cell lines A549 H1229 cells trans fected miR98 mimic increase expression Transfection miRNC control group Realtime PCR data indicated miR98 levels significantly higher miR98 group miRNC group Fig 2A B Further investiga tion showed overexpression miR98 caused sig nificant reduction cell proliferation Fig 2C D These findings suggest miR98 suppressive effect NSCLC growth We studied regulatory role miR98 NSCLC metastasis vitro performing wound healing Transwell assays The migration invasion capaci ties A549 H1229 cells significantly decreased overexpression miR98 compared miRNC group Fig 3AD MMP2 MMP9 important matrix metalloproteinases play key role tumor cell migration invasion Therefore examined protein expression group Western blot data showed protein levels MMP2 MMP9 significantly lower miR98 group compared miRNC group Fig 3E F Based data demonstrated miR98 suppressive effect NSCLC cell growth metastasis vitro SALL4 Is Target Gene miR98 NSCLC Cells We common bioinformatics soft ware predict putative target genes miR98 We SALL4 potential target gene miR98 perfect base pairing seed sequences miR98 data shown To confirm ings WT MTSALL43UTR luciferase reporter plasmids generated Fig 4A Luciferase reporter assay data indicated cotransfection miR98 mimic WTSALL43UTR luciferase reporter plas mid led significant decrease luciferase activ ity A549 H1229 cells compared control group eliminated cotransfection MTSALL43UTR luciferase reporter plasmid Fig 4B C Accordingly SALL4 target gene miR98 We showed overexpression miR98 significantly reduced protein expression SALL4 NSCLC cells Fig 5A B To confirm ings A549 H1229 cells transfected miR98 inhibitor downregulate expression After transfection miR98 levels reduced miR98 inhibitor group compared NC inhibitor group Fig 5C D We knockdown miR98 upregulated protein expression SALL4 NSCLC cells Fig 5E F Therefore miR98 negatively regulates protein expression SALL4 NSCLC cells miR98 INHIBITS NSCLC VIA TARGETING SALL4 979 Figure 2 miR98 inhibits proliferation NSCLC cells A549 H1229 cells transfected miR98 mimic scramble miR mimic miRNC A B Realtime RTPCR examine miR98 levels C D MTT assay performed examine cell proliferation p 005 p 001 versus miRNC SALL4 Is Upregulated NSCLC Reverse Correlated With miR98 Levels The expression level SALL4 determined NSCLC We mRNA levels SALL4 significantly upregulated NSCLC tissues com pared nontumor lung tissues Fig 6A Moreover inverse correlation observed miR98 SALL4 mRNA levels NSCLC tissues Fig 6B suggests upregulation SALL4 caused decreased expression miR98 NSCLC In addi tion examined expression SALL4 NSCLC cell lines normal lung epithelial BEAS2B cells We protein levels SALL4 significantly increased NSCLC cell lines compared BEAS2B cells Fig 6C SALL4 Is Involved miR98Mediated Growth Metastasis NSCLC Cells As SALL4 upregulated NSCLC negatively mediated miR98 studied SALL4 involved miR98mediated growth metastasis NSCLC cells miR98overexpressing A549 H1229 cells transfected pcDNA31 SALL4 expression plasmid The protein levels SALL4 significantly higher miR98 SALL4 group compared miR98 group Fig 7A B MTT assay data indicated cell pro liferation capacity increased miR98 SALL4 group compared miR98 group Fig 7C D suggesting suppressive effect miR98 NSCLC cell proliferation inhibition SALL4 Afterward migration invasion NSCLC cells significantly upregu lated miR98 SALL4 group compared miR98 group Fig 8AD Taken expression SALL4 eliminated suppressive effects miR98 malignant phenotypes A549 H1229 cells Therefore SALL4 acts downstream effector miR98mediated growth metastasis NSCLC cells 980 LIU ET AL miR98 INHIBITS NSCLC VIA TARGETING SALL4 981 Figure 4 SALL4 target gene miR98 NSCLC cells A Representation vectors containing wildtype WT mutanttype MT 3UTR SALL4 luciferase assay B C The luciferase activity notably decreased A549 H1229 cells cotransfected miR98 mimics WTSALL43UTR reporter plasmid unaltered A549 H1229 cells cotransfected miR98 mimics MTSALL43UTR plasmid p 001 versus miRNC Effects miR98 SALL4 NSCLC Growth In Vivo DISCUSSION We studied effects miR98 SALL4 NSCLC growth vivo miR98 SALL4 cloned pLPVSVG lentiviral vector The pLPVSVG miR98 pLPVSVGSALL4 plasmid stably transfected A549 cells After transfection miR98 SALL4 expression significantly increased compared control group transfected blank vector Fig 9A B Afterward nude mice subcutaneously implanted A549 cells group tumor grew gradually implantation The mice sacrificed 90th day implanta tion We SALL4 overexpression remarkably promoted tumor growth overexpression miR98 significantly suppressed tumor growth compared control group Fig 9C Tumor weight vol ume increased SALL4 group decreased miR98 group compared control group Fig 9D E These findings suggest miR98 inhibits NSCLC growth vivo directly targeting SALL4 A variety miRs demonstrated par ticipate development malignant progression NSCLC1123 underlying mechanism remains largely unclear Here reported miR98 signif icantly downregulated NSCLC associated disease progression Further investigation revealed miR98 inhibited proliferation migration invasion NSCLC cells vitro tumor growth vivo partly directly targeting SALL4 oncogene upregulated NSCLC miR98 demonstrated act tumor sup pressor oncogene different human cancers192024 It downregulated plays suppressive role glioma24 oral squamous cell carcinoma19 melanoma20 On contrary upregulated functions oncogene gastric cancer25 colon cancer26 small cell lung cancer27 The dual roles miR98 probably fact functions targeting different genes different cancers Recently miR98 reported significantly downregulated NSCLC plays FACING PAGE Figure 3 miR98 suppresses migration invasion NSCLC cells A549 H1229 cells transfected miR98 mimic scramble miR mimic miRNC Nontransfected A549 H1229 cells controls A B Wound healing assay C D Transwell assay performed determine cell migration invasion E F Western blot examine protein levels MMP2 MMP9 p 001 versus miRNC 982 LIU ET AL miR98 INHIBITS NSCLC VIA TARGETING SALL4 983 Figure 6 SALL4 upregulated NSCLC inversely correlated miR98 levels A Realtime qPCR conducted determine mRNA levels SALL4 NSCLC tissues n 88 nontumor lung tissues n 15 p 001 versus Normal B An inverse correlation observed miR98 SALL4 mRNA levels NSCLC tissues C Western blot examine protein levels SALL4 normal lung epithelial BEAS2B cells human NSCLC cell lines A549 HCC827 H1229 SKMES1 p 001 versus BEAS2B suppressive role2122 Ni et al miR98 targeted ITGB3 inhibit proliferation migration invasion NSCLC cells21 Yang et al showed miR98 inhib ited cell proliferation invasion nonsmall cell carcinoma lung cancer targeting PAK122 Moreover overexpression miR98 increase A549 cell spon taneous apoptosis sensitize cells cisplatin partly upregulation HMGA228 In addition upregu lation miR98 serum NSCLC patients asso ciated better outcomes radiotherapy29 Our study showed miR98 significantly downregulated NSCLC tissues cell lines compared nontumor lung tissues normal lung epithelial cells We showed low expression miR98 signif icantly associated poor differentiation advanced clinical stage NSCLC suggesting downregulation miR98 contribute malignant progression NSCLC NSCLC A549 H1229 cell lines investigate regulatory mechanism miR98 NSCLC growth metastasis We expression miR98 significantly suppressed pro liferation migration invasion A549 H1229 cells suggests miR98 inhibitory effect NSCLC growth metastasis SALL4 zinc finger transcription factor impor tant stem cell marker participating maintenance selfrenewal embryonic stem cells30 Recently SALL4 identified oncogene common cancer types3132 Yong et al reported SALL4 reexpressed subgroup patients hepato cellular carcinoma unfavorable prognosis33 Yue et al showed high expression SALL4 predicted FACING PAGE Figure 5 SALL4 negatively regulated miR98 NSCLC cells A B Western blot conducted examine protein expression SALL4 A549 H1229 cells transfected miR98 mimic scramble miR mimic miRNC p 001 versus miRNC Afterward A549 H1229 cells transfected miR98 inhibitor negative control NC inhibitor C D Realtime qPCR conducted determine miR98 levels E F Western blot conducted examine protein expression SALL4 p 001 versus NC inhibitor CF 984 LIU ET AL malignant phenotype poor prognosis breast inva sive ductal carcinoma34 In addition SALL4 oncogene glioma35 endometrial cancer36 intra hepatic cholangiocarcinoma37 colon cancer38 ALK ana plastic large cell lymphoma39 esophageal squamous cell carcinoma40 Recently Rodriguez et al reported high expression SALL4 correlated low differentiation NSCLC41 Kobayashi et al SALL4 upregulated lung cancer played promoting role cell proliferation42 Moreover SALL4 identified drugresistant factor lung cancer high expression SALL4 associated shorter period recurrence43 Therefore SALL4 potential therapeutic target NSCLC In addition miRs directly target SALL4 function tumor suppressors different cancers Cheng et al miR219 inhibited proliferation mig ration invasion colon cancer cells targeting SALL438 Lin et al reported miR33b suppressed breast cancer metastasis inhibition HMGA2 SALL4 Twist1 expression44 However miRrelated regulatory mechanism SALL4 expression NSCLC previously studied In present study showed SALL4 significantly upregulated NSCLC Figure 7 Overexpression SALL4 eliminates suppressive effects miR98 NSCLC cell proliferation A549 H1229 cells transfected miR98 mimic cotransfected miR98 mimic pcDNA31SALL4 expression plasmid A B Western blot conducted examine protein expression SALL4 C D MTT assay performed examine cell prolifera tion p 005 p 001 versus miR98 miR98 INHIBITS NSCLC VIA TARGETING SALL4 985 Figure 8 Overexpression SALL4 eliminates suppressive effects miR98 NSCLC cell migration invasion A549 H1229 cells transfected miR98 mimic cotransfected miR98 mimic pcDNA31SALL4 expression plas mid A B Wound healing C D Transwell assays performed determine cell migration invasion p 001 versus miR98 novel target miR98 protein expres sion SALL4 negatively regulated miR98 NSCLC cells Moreover overexpression SALL4 elim inated suppressive effects miR98 growth metastasis NSCLC cells vitro These findings suggest suppressive role miR98 NSCLC directly targeting SALL4 In vivo study supports conclusion overexpression miR98 reduced tumor growth A549 cells upregula tion SALL4 promoted NSCLC growth nude mice 986 LIU ET AL Figure 9 Effects miR98 SALL4 NSCLC growth vivo A549 cells stably transfected blank pLPVSVG vector control pLPVSVGmiR98 lentiviral plasmid pLPVSVGSALL4 lentiviral plasmid A Realtime qPCR ducted examine miR98 levels B Western blot examine protein levels SALL4 Nude mice subcutane ously implanted cells C On 90 days implantation nude mice group sacrificed xenograft obtained D Tumor weight E tumor volume calculated p 001 versus Control To knowledge present study showed miR98 acts tumor suppressor NSCLC directly targeting SALL4 time Therefore suggest miR98 SALL4 promising thera peutic candidates targets NSCLC ACKNOWLEDGMENT This study supported Hunan Provincial Natural Science Foundation China 14JJ20290 REFERENCES 1 2 3 Jemal A Bray F Center MM Ferlay J Ward E Forman D Global cancer statistics CA Cancer J Clin 2011616990 Torre LA Bray F Siegel RL Ferlay J LortetTieulent J Jemal A Global cancer statistics 2012 CA Cancer J Clin 20156587108 Greenlee RT Murray T Bolden S Wingo PA Cancer sta tistics 2000 CA Cancer J Clin 200050733 miR98 INHIBITS NSCLC VIA TARGETING SALL4 987 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Hall RD Le TM Haggstrom DE Gentzler RD Angio genesis inhibition therapeutic strategy nonsmall cell lung cancer NSCLC Transl Lung Cancer Res 20154 51523 Kang SM Lee HJ MicroRNAs human lung cancer Exp Biol Med Maywood 2014239150513 Li XB Gu JD Zhou QH Review aerobic glycolysis key enzymesNew targets lung cancer therapy Thorac Cancer 201561724 John B Enright AJ Aravin A Tuschl T Sander C Marks DS Human microRNA targets PLoS Biol 20042e363 Ambros V The functions animal microRNAs Nature 20044313505 Bartel DP MicroRNAs Genomics biogenesis mechanism function Cell 200411628197 Campayo M Navarro A Vinolas N Diaz T Tejero R Gimferrer JM Molins L Cabanas ML Ramirez J Monzo M Marrades R Low miR145 high miR367 asso ciated unfavourable prognosis resected nonsmall cell lung cancer Eur Respir J 20134111728 Capodanno A Boldrini L Proietti A Ali G Pelliccioni S Niccoli C DIncecco A Cappuzzo F Chella A Lucchi M Mussi A Fontanini G Let7g miR21 expression nonsmall cell lung cancer Correlation clinico pathological molecular features Int J Oncol 201343 76574 Chen X Zhu L Ma Z Sun G Luo X Li M Zhai S Li P Wang X Oncogenic miR9 target erlotinib NSCLCs Sci Rep 2015517031 Franchina T Amodeo V Bronte G Savio G Ricciardi GR Picciotto M Russo A Giordano A Adamo V Circulating miR22 miR24 miR34a novel predictive biomark ers pemetrexedbased chemotherapy advanced non small cell lung cancer J Cell Physiol 2014229979 Ren P Gong F Zhang Y Jiang J Zhang H MicroRNA92a promotes growth metastasis chemoresistance non small cell lung cancer cells targeting PTEN Tumour Biol 201637321525 Hu YK Wang X Li L Du YH Ye HT Li CY MicroRNA98 induces Alzheimers diseaselike disturbance target ing insulinlike growth factor 1 Neurosci Bull 201329 74551 Rizos E Siafakas N Katsantoni E Skourti E Salpeas V Rizos I Tsoporis JN Kastania A Filippopoulou A Xiros N Margaritis D Parker TG Papageorgiou C Zoumpourlis V Let7 mir98 mir183 biomarkers cancer schizophrenia corrected PLoS One 201510e0123522 Wendler A Keller D Albrecht C Peluso JJ Wehling M Involvement let7miR98 microRNAs regulation progesterone receptor membrane component 1 expres sion ovarian cancer cells Oncol Rep 2011252739 Wang CY Zhang JJ Hua L Yao KH Chen JT Ren XQ MicroRNA98 suppresses cell proliferation migration invasion targeting collagen triple helix repeat contain ing 1 hepatocellular carcinoma Mol Med Rep 201613 263944 Du Y Li Y Lv H Zhou S Sun Z Wang M miR98 sup presses tumor cell growth metastasis targeting IGF1R oral squamous cell carcinoma Int J Clin Exp Pathol 20158122529 Li F Li XJ Qiao L Shi F Liu W Li Y Dang YP Gu WJ Wang XG miR98 suppresses melanoma metastasis negative feedback loop target gene IL6 Exp Mol Med 201446e116 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 Ni R Huang Y Wang J miR98 targets ITGB3 inhibit proliferation migration invasion nonsmallcell lung cancer Onco Targets Ther 20158268997 Yang G Zhang X Shi J MiR98 inhibits cell proliferation invasion nonsmall cell carcinoma lung cancer targeting PAK1 Int J Clin Exp Med 201582013545 Chen Z Zeng H Guo Y Liu P Pan H Deng A Hu J miRNA145 inhibits nonsmall cell lung cancer cell pro liferation targeting cMyc J Exp Clin Cancer Res 201029151 Fan YH Ye MH Wu L Lv SG Wu MJ Xiao B Liao CC Ji QK Chai Y Zhu XG Overexpression miR98 inhibits cell invasion glioma cell lines downregula tion IKKepsilon Eur Rev Med Pharmacol Sci 201519 3593604 Yao Y Suo AL Li ZF Liu LY Tian T Ni L Zhang WG Nan KJ Song TS Huang C MicroRNA profiling human gastric cancer Mol Med Rep 2009296370 Pathak S Meng WJ Nandy SK Ping J Bisgin A Helmfors L Waldmann P Sun XF Radiation SN38 treatments modulate expression microRNAs cytokines chemokines colon cancer cells p53directed manner Oncotarget 20156424475880 Du L Schageman JJ Subauste MC Saber B Hammond SM Prudkin L Wistuba II Ji L Roth JA Minna JD Pertsemlidis A miR93 miR98 miR197 regulate expression tumor suppressor gene FUS1 Mol Cancer Res 20097123443 Xiang Q Tang H Yu J Yin J Yang X Lei X MicroRNA98 sensitizes cisplatinresistant human lung adenocarcinoma cells upregulation HMGA2 Pharmazie 201368 27481 Chen X Xu Y Liao X Liao R Zhang L Niu K Li T Li D Chen Z Duan Y Sun J Plasma miRNAs predicting radiosensitivity nonsmall cell lung cancer Tumour Biol 2016371192736 Chen X Vega VB Ng HH Transcriptional regulatory net works embryonic stem cells Cold Spring Harb Symp Quant Biol 2008732039 Zhang X Yuan X Zhu W Qian H Xu W SALL4 An emerging cancer biomarker target Cancer Lett 20153575562 Oishi N Yamashita T Kaneko S Molecular biology liver cancer stem cells Liver Cancer 201437184 Yong KJ Gao C Lim JS Yan B Yang H Dimitrov T Kawasaki A Ong CW Wong KF Lee S Ravikumar S Srivastava S Tian X Poon RT Fan ST Luk JM Dan YY SaltoTellez M Chai L Tenen DG Oncofetal gene SALL4 aggressive hepatocellular carcinoma N Engl J Med 2013368226676 Yue X Xiao L Yang Y Liu W Zhang K Shi G Zhou H Geng J Ning X Wu J Zhang Q High cytoplasmic expres sion SALL4 predicts malignant phenotype poor prognosis breast invasive ductal carcinoma Neoplasma 2015629808 Zhang L Yan Y Jiang Y Cui Y Zou Y Qian J Luo C Lu Y Wu X The expression SALL4 patients gliomas High level SALL4 expression correlated poor outcome J Neurooncol 20151212618 Li A Jiao Y Yong KJ Wang F Gao C Yan B Srivastava S Lim GS Tang P Yang H Tenen DG Chai L SALL4 new target endometrial cancer Oncogene 2015346372 Deng G Zhu L Huang F Nie W Huang W Xu H Zheng S Yi Z Wan T SALL4 novel therapeutic target intrahe patic cholangiocarcinoma Oncotarget 201562741626 988 38 39 40 LIU ET AL Cheng J Deng R Zhang P Wu C Wu K Shi L Liu X Bai J Deng M Shuai X Gao J Wang G Tao K miR2195p plays tumor suppressive role colon cancer targeting oncogene Sall4 Oncol Rep 201534192332 Wang P Zhang JD Wu F Ye X Sharon D Hitt M McMullen TP Hegazy SA Gelebart P Yang J Ma Y Lai R The expression oncogenic effects embryonic stem cell marker SALL4 ALKpositive anaplastic large cell lymphoma Cell Signal 201224195563 Forghanifard MM Ardalan Khales S JavdaniMallak A Rad A Farshchian M Abbaszadegan MR Stemness state regulators SALL4 SOX2 involved progression invasiveness esophageal squamous cell carcinoma Med Oncol 201431922 41 42 43 44 Rodriguez E Chen L Ao MH Geddes S Gabrielson E Askin F Zhang H Li QK Expression transcript factors SALL4 OCT4 subset nonsmall cell lung carci nomas NSCLC Transl Respir Med 2014210 Kobayashi D Kuribayashi K Tanaka M Watanabe N Overexpression SALL4 lung cancer impor tance cell proliferation Oncol Rep 20112696570 Yanagihara N Kobayashi D Kuribayashi K Tanaka M Hasegawa T Watanabe N Significance SALL4 drug resistant factor lung cancer Int J Oncol 201546152734 Lin Y Liu AY Fan C Zheng H Li Y Zhang C Wu S Yu D Huang Z Liu F Luo Q Yang CJ Ouyang G MicroRNA 33b inhibits breast cancer metastasis targeting HMGA2 SALL4 Twist1 Sci Rep 201559995